Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Thaman who wrote (1597)	6/22/1998 8:25:00 PM
From: Ripley	Respond to of 5402

Flavopiridol Induces Apoptosis of Normal Lymphoid Cells, Causes Immunosuppression, and Has Potent Antitumor Activity In Vivo Against Human Leukemia and Lymphoma Xenografts Blood, Vol. 91 No. 7 (April 1), 1998: pp. 2482-2490 c 1998 by The American Society of Hematology.

To: Joe Thaman who wrote (1597)	6/22/1998 8:37:00 PM
From: drdan	Respond to of 5402

Joe, I don't know the journal that you checked , but if you look at the info thread and call the Sanguine offices, you can find much info that interests you. If you feel very ambitious(or anyone else for that matter), here is a source for the most up to date published data on these products: Current Issues in Blood Substitute Research and Development;Univ. of Calif. San Diego , March 1997.This is available in a medical library, but I dont know if it s over the 'Net.Happy hunting.